Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Cipla
Chinese Patent Office
Covington
Healthtrust
Chubb
Medtronic
Queensland Health
Accenture
AstraZeneca

Generated: August 21, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: buprenorphine hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Indivior Inc
BUPRENEX
buprenorphine hydrochloride
INJECTABLE;INJECTION018401NDAReckitt Benckiser Pharmaceuticals Inc12496-0757-55 AMPULE in 1 CARTON (12496-0757-5) > 1 mL in 1 AMPULE (12496-0757-1)
Actavis Elizabeth
BUPRENORPHINE HYDROCHLORIDE
buprenorphine hydrochloride
TABLET;SUBLINGUAL090819ANDAActavis Pharma, Inc.0228-3153-0330 TABLET in 1 BOTTLE (0228-3153-03)
Actavis Elizabeth
BUPRENORPHINE HYDROCHLORIDE
buprenorphine hydrochloride
TABLET;SUBLINGUAL090819ANDAActavis Pharma, Inc.0228-3153-0990 TABLET in 1 BOTTLE (0228-3153-09)
Actavis Elizabeth
BUPRENORPHINE HYDROCHLORIDE
buprenorphine hydrochloride
TABLET;SUBLINGUAL090819ANDAActavis Pharma, Inc.0228-3153-7330 TABLET in 1 BLISTER PACK (0228-3153-73)
Actavis Elizabeth
BUPRENORPHINE HYDROCHLORIDE
buprenorphine hydrochloride
TABLET;SUBLINGUAL090819ANDAActavis Pharma, Inc.0228-3156-0330 TABLET in 1 BOTTLE (0228-3156-03)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
McKinsey
US Department of Justice
Fuji
Boehringer Ingelheim
UBS
US Army
Federal Trade Commission
Dow
Argus Health

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot